Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

International Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 887-894

  Wu, Tony T ^a   Sikes, Robert A ^a   Cui, Quanjun ^a   Thalmann, George N ^c   Kao, Chinghai ^a   Murphy, Cheryl F ^b   Yang, Hua ^a   Zhau, Haiyen E ^a   Balian, Gary ^a   Chung, Leland W K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER; RETROPERITONEAL CANCER; SCID MOUSE; SPINE METASTASIS; TUMOR XENOGRAFT;

EID: 0031849770     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z     Document Type: Article

References (38)

1. BERLIN, Ö., SAMID, D., DONTHINENI-RAO, R., AKESON, W., AMIEL, D., and WOODS, V.L., Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res., 53, 4890-4895 (1993).
2. BERRETTONI, B.A. and CARTER, J.R., Mechanisms of cancer metastasis to bone. J. Bone Joint Surg., 68, 308-312 (1986).
3. BORING, C.C., SQUIRES, T.S., TONG, T. and MONTGOMERY, S., Cancer statistics, 1994. CA: Cancer J. Clin., 44, 7-26 (1994).
4. CATALONA, W.J., SMITH, D.S., RATLIFF, T.L. and BASLER, J.W., Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J. Amer. med. Ass., 270, 948-954 (1993).
5. CATALONA, W.J., SMITH, D.S., RATLIFF, T.L., DODDS, K.M., COPLEN, D.E., YUAN, J.U., PETROS, J.A. and ANDRIOLE, G.L., Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324, 1156-1161 (1991).
6. CHANG, S.M. and CHUNG, L.W., Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology, 125, 2719-2727 (1989).
7. 125I-5-iodo-2″ deoxyuridine. J. natl. Cancer Inst., 45, 773-782 (1970).
8. FRANK, L.M., Etiology, epidemiology and pathology of prostate cancer. Cancer, 32, 1092-1095 (1997).
9. FU, X., HERRERA, H. and HOFFMAN, R.M., Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue [Letter]. Int. J. Cancer, 52, 987-990 (1992).
10. GHOSSEIN, R.A., SCHER, H.I., GERALD, W.L., KELLY, W.K., CURLEY, T., AMSTERDAM, A., ZHANG, Z.F. and ROSAI, J., Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. clin. Oncol., 13, 1195-1200 (1995).
11. HAQ, M-, GOLTZMAN, D., TREMBLAY, G. and BRODT, P., Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res., 52, 4613-4619 (1992).
12. HOROSZEWICZ, J.S., LEONG, S.S., CHU, T.M., WAJSMAN, Z.L., FRIEDMAN, M., PAPSIDERO, L., KIM, U., CHAI, L.S., KAKATI, S., ARYA, S.K. and SANDBERG, A.A., The LNCaP cell line - a new model for studies on human prostatic carcinoma. Prog. clin. biol. Res., 37, 115-132 (1980).
13. HOROSZEWICZ, J.S., LEONG, S.S., KAWINSKI, E., KARR, J.P., ROSENTHAL, H., CHU, T.M., MIRAND, E.A. and MURPHY, G.P., LNCaP model of human prostatic carcinoma. Cancer Res., 43, 1809-1818 (1983).
14. HYYTINEN, E.-R., THALMANN, G.N., ZHAU, H.E., KARHU, R., KALLIONIEMI, O.-P-, CHUNG, L.W.K. and VISAKORPI, T., Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Brit. J. Cancer, 75, 190-195 (1997).
15. ISRAELI, R.S., MILLER, W.H., JR., SU, S.L., POWELL, C.T., FAIR, W.R., SAMADI, D.S., HURYK, R.F., DEBLASIO, A., EDWARDS, E.T., WISE, G.J. and HESTON, D.W., Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54, 6306-6310 (1994).
16. ISRAELI, R.S., MILLER, W.H., JR., SU, S.L., SAMADI, D.S., POWELL, C.T., HESTON, D.W., WISE, G.J. and FAIR, W.R., Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane antigen-derived primers in the polymerase chain reaction. J. Urol., 153, 573-577 (1995).
17. KAIGHN, M.E., NARAYAN, K.S., OHNUKI, Y., LECHNER, J.F. and JONES, L.W., Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 17, 16-23 (1979).
18. KLEIN, K., REITER, R., REDULLA, J., MORADI, H., ZHU, X., BROTHMAN, A., LAMB, D., MARCELLI, M., BELLDEGRUN, A., WITTE, O. and SAWYERS, C., Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nature (Med.), 3, 402-408 (1997).
19. MILLER, A.D. and ROSMAN, G.J., Improved retroviral vectors for gene transfer and expression. BioTechniques, 7, 980-990 (1989).
20. MORENO, J.G., CROCE, C.M., FISCHER, R., MONNE, M., VIHKO, P., MULHOLLAND, S.G. and GOMELLA, L.G., Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res, 52, 6110-6112 (1992).
21. NAGABHUSHAN, M., MILLER, D.M., PRETLOW, T.P., GIACONIA, J.M., EDGEHOUSE, N.L., SCHWARTZ, S., KUNG, H.J., DE VERE WHITE, R.W., GUMER- LOCK, P.H., RESNICK, M.I., AMINI, S.B. and PRETLOW, T.G., The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res., 56, 3042-3046 (1996).
22. PARKER, S.L., TONG, T., BOLDEN, B.A. and WINGO, P.A., Cancer statistics. CA: Cancer J. Clin., 47, 5-27 (1997).
23. PETTAWAY, C.W., PATHALE, S., GREENE, G., RAMIREZ, E., WILSON, M.R., KILLION, J.J. and FIDLER, I.J., Selection of highly metastatic variants of different human prostate carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res., 2, 1627-1636 (1996).
24. POLLARD, M., LUCKERT, PH. and SCHEU, J., Effects of diphosphonate and X-rays on bone lesions induced in rats by prostate cancer cells. Cancer, 61, 2027-2032 (1988).
25. SASAKI, A., BOYCE, B.F., STORY, B., WRIGHT, K.R., CHAPMAN, M., BOYCE, R., MUNDY, G.R. and YONEDA, T., Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res., 55, 3551-3557 (1995).
26. SATO, N., GLEAVE, M., BRUCHOVSKY, N., RENNTE, P., BERALDI, E. and SULLIVAN, L., A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res., 57, 1584-1589 (1997).
27. SCHER, H.I. and CHUNG, L.W.K., Bone metastases: improving the therapeutic index. Semin. Oncol., 21, 630-656 (1994).
28. SHEVRIN, D.H., GORNY, K.I. and KUKREJA, S.C., Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice. Prostate, 15, 187-194 (1989).
29. SHEVRIN, D.H., KUKREJA, S.C., GHOSH, L. and LAD, T.E., Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin. exper. Metastasis, 6, 401-409 (1988).
30. SIKES, R.A. and CHUNG, L.W., Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res., 52, 3174-3181 (1992).
31. SOOS, G., ZUKOWSKI, K., JONES, R.F., HAAS, G.P. and WANG, C.Y., Heterotypic growth of human prostate carcinoma in the femurs of nude mice: an osseous metastatic model. Intern. J. Cancer, 66, 280-281 (1996).
32. STAMEY, T.A. and MCNEAL, J.E., Adenocarcinoma of the prostate. In: P.C. Walsh, A.B. Retik, T.A. Stamey and E.D. Vaughan (eds.), Campbell's urology, pp. 1159-1199, Saunders, Philadelphia (1992).
33. STEPHENSON, R.A., DINNEY, C.P., GOHJI, K., ORDONEZ, N.G., KILLION, J.J. and FIDLER, I.J., Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. natl. Cancer Inst., 84, 951-957 (1992).
34. STORMONT, T.J., FARROW, G.M., MYERS, R.P., BLUTE, M.L., ZINCKE, H., WILSON, T.M. and OESTERLING, J.E., Clinical stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated prostate-specific antigen concentration. Urology, 41, 3-8 (1993).
35. THALMANN, G.N., ANEZINIS, P.E., CHANG, S.M., ZHAU, H.E., KIM, E.E., HOPWOOD, V.L., PATHAK, S., VON ESCHENBACH, A.C. and CHUNG, L.W., Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer [published erratum appears in Cancer Res., 54, 3953 (1994)]. Cancer Res., 54, 2577-2581 (1994).
36. WANG, M. and STEARNS, M.E., Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in SCID mice. Differentiation, 48, 115-125 (1991).
37. WEISS, L., ORR, F.W. and HONN, U.V., Interactions of cancer cells with the microvasculature during metastasis. FASEB J., 2, 12-21 (1988).
38. WU, H.C., HSIEH, J.T., CLEAVE, M.E., BROWN, N.M., PATHAK, S. and CHUNG, L.W., Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Inter. J. Cancer, 57, 406-412 (1994).